Health Catalyst, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Dr. Jill Hoggard Green

Health Catalyst, Inc.’s own tally for this item (“Elect Director: Dr. Jill Hoggard Green”): 45,320,332 for, 1,218,774 withheld, per its Form 8-K filed July 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The Company's stockholders elected each of the two persons named below to serve as a Class III director of the Company to serve a three-year term expiring at the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subj…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 17,975,336 for, 12,266 withheld.

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

Description as filed by funds: Election of two Class III Directors for a term of three years until the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation: Duncan Gallagher

Health Catalyst, Inc.’s own tally for this item (“Elect Director: Duncan Gallagher”): 37,136,561 for, 9,402,545 withheld, per its Form 8-K filed July 10, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 – Election of Directors The Company's stockholders elected each of the two persons named below to serve as a Class III director of the Company to serve a three-year term expiring at the 2028 annual meeting of the stockholders or until their successors are duly elected and qualified, subj…”
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 51 asset managers below reported 14,763,775 for, 3,147,378 withheld, 76,449 abstained.

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

Description as filed by funds: TO APPROVE, ON AN ADVISORY, NON-BINDING BASIS, THE BOARD INITIATING ACTION TO DECLASSIFY THE BOARD.

Health Catalyst, Inc.’s own tally for this item (“4. Advisory, Non-Binding Vote to Approve the Board of Directors Initiating Action to Declassify our Board of Directors of the Company”): 46,174,256 for, 345,811 against — passed, per its Form 8-K filed July 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 – Advisory, Non-Binding Vote to Approve the Board of Directors Initiating Action to Declassify our Board of Directors of the Company The stockholders approved the advisory, non-binding proposal to approve the board of directors of the Company (the "Board of Directors") initiating action …”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 18,058,077 for.

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

Description as filed by funds: To approve, on an advisory, non-binding basis, the compensation of our named executive officers.

Health Catalyst, Inc.’s own tally for this item (“3. Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers”): 45,000,705 for, 768,325 against — passed, per its Form 8-K filed July 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Advisory, Non-Binding Vote to Approve the Compensation of the Company's Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company's named executive officers.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 54 managers: 17,962,151 for, 111,017 against, 12,025 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 126 managers: 32,777,036 for, 165,450 against, 40,742 abstained. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF HEALTH CATALYST, INC. FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.

Health Catalyst, Inc.’s own tally for this item (“2. Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm”): 53,070,196 for, 26,656 against — passed, per its Form 8-K filed July 10, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm The Company's stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company's consolidated financial statements for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 53 asset managers below reported 18,046,052 for, 12,025 abstained.

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.